semaglutide news october 2025 Older Americans Quit Weight Loss Drugs in Droves EUREKA! The Top Endocrine Science

Our team provides this FDA-approved treatment to help reduce appetite and promote sustainable weight loss

Pain Point: Limited Access and Geographic Barriers Many individuals living in rural or underserved communities lack access to specialists capable of managing obesity or prescribing advanced therapies

In comparison, Mounjaros KwikPen ranges from Rs 14,000 (2.5 mg) to Rs 27,500 (15 mg)

54 The LEAN trial first evaluated the anti-steatotic effects of liraglutide in patients with MASH

In addition, the small sample size (four studies) and variability in reporting hindered the ability to pool data effectively

This short lifespan means that the effects of GLP-1 and GIP to lower hunger are often short-lived